Christopher B. Ehrlich - Interim Chairman and CEO, Director at Cero Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim Chairman and CEO, Director
Stock Symbol
CERO, CEROW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher B. Ehrlich since 11/22/2023

Holdings reported by Christopher B. Ehrlich for Cero Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.79M $579K $0.10 Sep 25, 2024 Direct
Common Stock 3.6K $360 $0.10 Sep 25, 2024 By Spouse
Series A Convertible Preferred Stock 0 $0 $1,000.00 Sep 25, 2024 Direct Common Stock
Warrants 5K Feb 14, 2024 Direct Common Stock
Stock Option (Right to Buy) 0 Sep 30, 2024 Direct Common Stock
Convertible Promissory Note 0 Feb 14, 2024 By Phoenix Biotech Sponsor, LLC Common Stock
Warrants 0 Feb 14, 2024 By Phoenix Biotech Sponsor, LLC Common Stock

Transactions reported by Christopher B. Ehrlich for Cero Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.